Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Cancer02:18

Cancer

55.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
What is Cancer?02:12

What is Cancer?

5.9K
5.9K
What is Cancer?02:12

What is Cancer?

15.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
15.8K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Axillary Recurrence and Survival After Omission of Axillary Lymph Node Dissection in Patients with Breast Cancer and Micrometastases or Isolated Tumor Cells in the Sentinel Node: A Danish National Register Study.

Annals of surgical oncology·2026
Same author

Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study.

Archives of gynecology and obstetrics·2026
Same author

The impact of drains on postoperative seroma and infection after mastectomy: A retrospective study in Danish women with breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Involving patient partners as appraisers of shared decision making: an explanatory sequential mixed-methods study.

Research involvement and engagement·2026
Same author

Updated International Patient Decision Aid Standards (IPDAS version 5.0): modified Delphi, evidence informed consensus process.

BMJ (Clinical research ed.)·2026
Same author

Exploration of between-hospital variation and the basis for decision making in management of malignant colorectal polyps- a Danish population-based study.

World journal of surgical oncology·2026

Related Experiment Video

Updated: Apr 6, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.8K

[Cancer in pregnancy].

Berit Woetmann Pedersen1, Lone Storgaard, Mette Borg Clausen

  • 1Obstetrisk Klinik, Juliane Marie Centret, Rigshospitalet, Blegdamsvej 9, 2100 København Ø. berit.woetmann.pedersen@regionh.dk.

Ugeskrift for Laeger
|August 5, 2015
PubMed
Summary

Cancer during pregnancy, affecting 1 in 1,000 pregnancies, can be safely treated in most cases during the second and third trimesters. Management involves multidisciplinary care and delayed delivery post-chemotherapy.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.9K

Related Experiment Videos

Last Updated: Apr 6, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.8K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.9K

Area of Science:

  • Obstetrics and Gynecology
  • Oncology
  • Perinatal Medicine

Background:

  • Cancer complicates approximately 1 in 1,000 pregnancies.
  • Recent evidence indicates safety of most cancer treatments during the second and third trimesters for both mother and fetus.
  • This has prompted a shift in managing cancer in pregnant individuals.

Purpose of the Study:

  • To outline the current paradigm shift in treating cancer during pregnancy.
  • To emphasize the importance of multidisciplinary management and optimized delivery timing.

Main Methods:

  • Review of recent reports and clinical guidelines on cancer treatment in pregnancy.
  • Analysis of safety data for chemotherapy in second and third trimesters.
  • Discussion of optimal timing for delivery relative to chemotherapy.

Main Results:

  • Most chemotherapy regimens are safe for mother and child in the second and third trimesters.
  • Multidisciplinary management is crucial for optimal outcomes.
  • Postponing delivery 2-3 weeks after the last chemotherapy session allows for maternal and fetal bone marrow recovery.

Conclusions:

  • Cancer in pregnancy requires a coordinated, multidisciplinary approach.
  • Chemotherapy during the second and third trimesters is generally safe.
  • Strategic timing of delivery is essential to mitigate risks associated with preterm birth and chemotherapy side effects.